Current issues in the treatment of anxiety states and disorders
Psychopharmacology Bulletin 18(1): 36-43
1982
ISSN/ISBN: 0048-5764 PMID: 7089159 Document Number: 190871
Document emailed within 1 workday
Related Documents
Riemann, D. 1996: Anxiety disorders. Diagnosis and therapy in family practice. 1: Anxiety reactions--psychiatric disorders and anxiety--anxiety disorders Fortschritte der Medizin 114(33): 457-459Salzman, C.; Goldenberg, I.; Bruce, S.E.; Keller, M.B. 2001: Pharmacologic treatment of anxiety disorders in 1989 versus 1996: results from the Harvard/Brown anxiety disorders research program Journal of Clinical Psychiatry 62(3): 149-152
Greenhill, L.L.; Pine, D.; March, J.; Birmaher, B.; Riddle, M. 1998: Assessment issues in treatment research of pediatric anxiety disorders: what is working, what is not working, what is missing, and what needs improvement Psychopharmacology Bulletin 34(2): 155-164
Bouvard, A.; Doumy, O.; Bienvenu, T.; Aouizerate, B. 2019: Current nosographic classifications of anxiety disorders La Revue du Praticien 69(9): 970-973
Brzeziński, R.; Rybakowski, J.; Dabkowski, M. 1987: Current concepts of various anxiety disorders: "panic attacks" Psychiatria Polska 21(6): 509-517
Ozaki, N.; Igarashi, Y. 2010: The current role of rehabilitation in depression and anxiety disorders--therapeutic significance of re-work programs Seishin Shinkeigaku Zasshi 112(3): 236-237
Pratt, M.; Macera, C.A.; Blanton, C. 1999: Levels of physical activity and inactivity in children and adults in the United States: current evidence and research issues Medicine and Science in Sports and Exercise 31(11 Suppl): S526-S533
James, I.M. 1984: Practical aspects of the use of beta-blockers in anxiety states: situational anxiety Postgraduate Medical Journal 60(Suppl 2): 19-25
Bertin, I.; Colombo, G.; Gamba, P.G.; Pasquali, C.; Furlanut, M. 1986: Clinical evaluation of clotiazepam in the ambulatory treatment of anxiety states Rivista di Neurologia 56(5): 276-285
Volz, H.-P. 2008: Diagnosis and treatment of anxiety disorders MMW Fortschritte der Medizin 150(Suppl 2): 64-67
Motak, E. 1987: The DSM IIi classification of anxiety disorders in the light of psychological models of anxiety Psychiatria Polska 21(6): 533-539
Chevalier, A.; Bonenfant, S.; Picot, M.C.; Chastang, J.F.; Luce, D. 1996: Occupational factors of anxiety and depressive disorders in the French National Electricity and Gas Company. The Anxiety-Depression Group Journal of Occupational and Environmental Medicine 38(11): 1098-1107
Garakani, A.; Mathew, S.J.; Charney, D.S. 2006: Neurobiology of anxiety disorders and implications for treatment Mount Sinai Journal of Medicine new York 73(7): 941-949
Lyles, W.B.; Simpson, B. 1990: Advances in treatment of anxiety and depressive disorders Journal of the Florida Medical Association 77(8): 731-734
Rzewuska, M.; Sobucka, K. 1993: Buspirone in the treatment of Generalized Anxiety Disorders Psychiatria Polska 27(5): 545-561
Allgulander, C.; Hirschfeld, R.M.A.; Nutt, D.J. 2002: Long-term treatment strategies in anxiety disorders Psychopharmacology Bulletin 36(Suppl 2): 79-92
Pigott, T.A. 1999: Gender differences in the epidemiology and treatment of anxiety disorders Journal of Clinical Psychiatry 60(Suppl 18): 4-15
De Mesmaeker, S.ép.; Zdanowicz, N.; Reynaert, C.; Jacques, D. 2014: Role of benzodiazepines in the treatment of anxiety disorders in 2014 Psychiatria Danubina 26(Suppl 1): 23-26
Nemeroff, C.B. 2003: The role of GABA in the pathophysiology and treatment of anxiety disorders Psychopharmacology Bulletin 37(4): 133-146
Lemoine, P.; Rouillon, F.; Pouget, D. 1996: Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders L'Encephale 22(6): 461-467